Divyamani Srinivasan

2006

A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Whom Divyamani Srinivasan trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. J. P. Thiery
  2. Thomas Holbro

Who trusts Divyamani Srinivasan overall

  1. Mahmut Yilmaz

Papers from Divyamani Srinivasan's perspective

Ordered by how strongly the researchers Divyamani Srinivasan trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Epithelial–mesenchymal transitions in tumour progression (Nature Reviews. Cancer)
  2. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. (New England Journal of Medicine)
  3. ErbB receptors: directing key signaling networks throughout life. (Annual Review of Pharmacology and Toxicology)
  4. Structural basis for the autoinhibition of c-Abl tyrosine kinase. (Cell)
  5. Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered… (Journal of Clinical Oncology)
  6. Contact Inhibition of Locomotion in vivo controls neural crest directional migration (Nature)
  7. Inflammation and EMT: an alliance towards organ fibrosis and cancer progression (EMBO Molecular Medicine)
  8. EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization. (Molecules and Cells)
  9. Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab (Nature)
  10. The ErbB signaling network: receptor heterodimerization in development and cancer (EMBO Journal)

Their papers